Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics by Lally J, Gaughran F, Timms P, Curran SR

Get full text

Predictors of falls and fractures leading to hospitalization in people with schizophrenia spectrum disorder: A large representative cohort study by Stubbs, B, Mueller, C, Gaughran, F, Lally, J, Vancampfort, D, Lamb, S, Koyanagi, A, Sharma, S, Stewart, R, Perera, G

"It's valid and reliable" is not enough critical appraisal of reporting of measures in trials evaluating patient decision Aids by Sepucha, K.R., Matlock, D.D., Wills, C.E., Ropka, M., Joseph-Williams, N., Stacey, D., Ng, Chirk Jenn, Levin, C., Lally, J., Borkhoff, C.M.

Establishing the effectiveness of patient decision aids: key constructs and measurement instruments by Sepucha, K.R., Borkhoff, C.M., Lally, J., Levin, C.A., Matlock, D.D., Ng, C.J., Ropka, M.E., Stacey, D., Joseph-Williams, N., Wills, C.E., Thomson, R.

Get full text

Longitudinal changes in DNA methylation associated with clozapine use in treatment-resistant schizophrenia from two international cohorts by Gillespie, AL, Walker, EM, Hannon, E, McQueen, GA, Sendt, K, Avila, A, Lally, J, Okhuijsen-Pfeifer, C, van der Horst, M, Hasan, A, Dempster, EL, Burrage, J, Bogers, J, Cohen, D, Boks, MP, Collier, DA, Egerton, A, Luykx, JJ, Mill, J, MacCabe, JH